Home › Interstitial Lung Diseases › Texas › Houston
Pag-aaral pangklinika para sa Interstitial Lung Diseases sa Houston, TX
Isang pag-aaral para sa Interstitial Lung Diseases ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Nagre-recruitPhase 3
- Baylor College of Medicine, Houston
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Nagre-recruitPhase 2
- Baylor College of Medicine, Houston
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Nagre-recruitObservasyonal na pag-aaral
- Baylor College of Medicine, Houston
- Houston Methodist Lung Center, Houston
- The University of Texas Health Science Center At Houston, Houston
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Nagre-recruit
- Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
- The University of Texas Health Science Center Houston, Houston
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Nagre-recruitPhase 2
- Houston Methodist Hospital, Houston
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Nagre-recruitPhase 3
- GSK Investigational Site, Houston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Nagre-recruitPhase 2
- Clinical Research Site, Houston
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Nagre-recruitObservasyonal na pag-aaral
- Houston Methodist, Houston
- University of Texas Health Science Center at Houston, Houston
Platform Clinical Study for Conquering Scleroderma
Nagre-recruitPhase 2
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Nagre-recruitPhase 3
- Houston Methodist Outpatient Center, Houston
- The University of Texas Health Science Center at Houston, McGovern Medical School, Houston
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
Nagre-recruitObservasyonal na pag-aaral
- Baylor College of Medicine/Texas Children'S Hospital, Houston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Nagre-recruitPhase 2
- aTyr Investigative Site, Houston
Pag-aaral para sa Interstitial Lung Diseases sa ibang lungsod
- New York City, NY17 pag-aaral
- Philadelphia, PA16 pag-aaral
- Los Angeles, CA14 pag-aaral
- Kansas City, KS13 pag-aaral
- Durham, NC13 pag-aaral
- Chicago, IL12 pag-aaral
- Charleston, SC11 pag-aaral
- Ann Arbor, MI11 pag-aaral
- Aurora, CO10 pag-aaral
- Boston, MA9 pag-aaral
- Rochester, MN9 pag-aaral
- Salt Lake City, UT9 pag-aaral
Iba pang pag-aaral sa Houston
- Non-Small Cell Lung Cancer143 pag-aaral
- Kanser sa Suso126 pag-aaral
- Kanser (lahat ng uri)124 pag-aaral
- Colorectal Cancer101 pag-aaral
- Metastatic Cancer100 pag-aaral
- Kanser sa Ovary90 pag-aaral
- Acute Myeloid Leukemia88 pag-aaral
- Kanser sa Baga78 pag-aaral
- Kanser sa Prostate73 pag-aaral
- Kanser ng Endometrium69 pag-aaral
- Melanoma61 pag-aaral
- Kanser sa Pancreas59 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.